Freeport-McMoRan Inc:企業のM&A・事業提携・投資動向

◆英語タイトル:Freeport-McMoRan Inc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
◆商品コード:DATA904C1805
◆発行会社(調査会社):MarketLine
◆発行日:2018年7月
◆ページ数:68
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:金属・鉱業
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD350 ⇒換算¥51,800見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD700 ⇒換算¥103,600見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD1,050 ⇒換算¥155,400見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はMarketLine社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
MarketLine社の概要はこちらでご確認いただけます。



【レポートの概要】

Freeport-McMoRan Inc – Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
Summary

Marketline’s Freeport-McMoRan Inc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capital raisings, venture capital investments, ownership and partnership transactions undertaken by Freeport-McMoRan Inc since January2007.

Synopsis

Marketline’s Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage.

Key Highlights

This report includes Freeport-McMoRan Inc’s contact information and business summary, tables, graphs, a list of partners and targets, a breakdown of financial and legal advisors, deal types, top deals by deal value, detailed deal reports, and descriptions and contact details of the partner, target, investor, and vendor firms, where disclosed.

The profile also includes detailed deal reports for all M&A, private equity, public offering, venture financing, partnership and divestment transactions undertaken by Freeport-McMoRan Inc. These deal reports contain information about target company financials, sources of financing, method of payment, deal values, and advisors for various parties, where disclosed.

Scope

- Provides intelligence on Freeport-McMoRan Inc’s M&A, strategic partnerships and alliances, capital raising and private equity transactions.
- Detailed reports of various financial transactions undertaken by Freeport-McMoRan Inc and its subsidiaries since 2007.
- Information about key financial and legal advisors for Freeport-McMoRan Inc’s financial deals transactions.
- Financial deals tables and charts covering deal value and volumes trend, deal types and geography-based deal activity.

Reasons to buy

- Access comprehensive financial deals data along with charts and graph covering M&A, private equity, and partnerships and alliances.
- Form an independent opinion about Freeport-McMoRan Inc’s growth strategies through the organic and inorganic activities undertaken since 2007.
- Track your competitors’ business structure and growth strategies.

【レポートの目次】

Table of Contents
COMPANY OVERVIEW AND KEY FACTS 2
TABLE OF CONTENTS 5
LIST OF TABLES 6
LIST OF FIGURES 6
MERGERS & ACQUISITIONS 7
Mergers and Acquisitions – Deal reports 7
CORPORATE VENTURING 24
Corporate Venturing – Deal reports 24
PARTNERSHIP 27
Partnership – Deal reports 27
CAPITAL RAISING 29
Capital Raising – Deal reports 29
DIVESTMENTS 35
Divestments – Overview 35
Divestments – Deal reports 36
PRIVATE EQUITY & OWNERSHIP 56
Private Equity and Ownership – Deal reports 56
APPENDIX 58
Contact Us 58
About MarketLine Financial Deals Database 58
Deal Definition and Methodology 60
About MarketLine 67

List of Tables
Table 1: Freeport-McMoRan Inc. divestments volume and value trend (2014-YTD2018)
Table 2: Freeport-McMoRan Inc. divestments activity by geography (2014-YTD2018)

List of Figures
Figure 1: Freeport-McMoRan Inc. divestments volume and value trend (2014-YTD2018)
Figure 2: Freeport-McMoRan Inc. divestments by geography (2014-YTD2018)

★海外企業調査レポート[Freeport-McMoRan Inc:企業のM&A・事業提携・投資動向]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • PledPharma AB (PLED):製薬・医療:M&Aディール及び事業提携情報
    Summary PledPharma AB (PledPharma) is a pharmaceutical company that discovers, manufactures, and develops drugs that protect the body against oxidative stress. The company discovers and develops Aladote and PledOx drugs. Its PledOX drug is used to prevent chemotherapy-induced side effects for colore …
  • Koch Enterprises, Inc.:企業の戦略的SWOT分析
    Koch Enterprises, Inc. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • Control4 Corporation (CTRL)-エネルギー分野:企業M&A・提携分析
    Summary Control4 Corporation (Control4) is a provider of automation systems and control solutions for homes and businesses. It focuses on smart lighting, networking solutions and safety and security solutions. The company offers personalized control solutions for lighting, video, music, energy and s …
  • Insperity Inc (NSP):企業の財務・戦略的SWOT分析
    Insperity Inc (NSP) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and t …
  • MaaT Pharma-製薬・医療分野:企業M&A・提携分析
    Summary MaaT Pharma (MaaT) is a biotechchnology company that develop novel treatments for Gut Microbiota - dysbiosis related diseases. The company is working on two projects, which are in the developmental stage, namely, MaaT001, an innovative live frozen inoculum suspension and MaaT002, an innovati …
  • TransAlta Corporation:企業の戦略・SWOT・財務分析
    TransAlta Corporation - Strategy, SWOT and Corporate Finance Report Summary TransAlta Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Laing O’Rourke Plc:企業の戦略的SWOT分析
    Laing O'Rourke Plc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and ser …
  • SK Chemicals Co Ltd (006120):企業の財務・戦略的SWOT分析
    Summary SK Chemicals Co Ltd (SK Chemicals) is a provider of chemical and pharmaceutical products. The company offers pharmaceutical drugs to treat erectile dysfunction, arthritis, peptic ulcer, gastroesophageal reflux disease (GERD), cancer and to improve blood circulation. It manufactures green che …
  • McKinsey & Company, Inc.:戦略・SWOT・企業財務分析
    McKinsey & Company, Inc. - Strategy, SWOT and Corporate Finance Report Summary McKinsey & Company, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • SAE Towers Holdings LLC:企業の戦略的SWOT分析
    SAE Towers Holdings LLC - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products an …
  • Universal Travel Group:企業の戦略・SWOT・財務分析
    Universal Travel Group - Strategy, SWOT and Corporate Finance Report Summary Universal Travel Group - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • GenSight Biologics SA (SIGHT):製薬・医療:M&Aディール及び事業提携情報
    Summary GenSight Biologics SA (GenSight) is a clinical stage biotechnology company that discovers and develops novel therapies for mitochondrial and neurodegenerative diseases. The company’s product pipeline comprises GS010 and GS030 developed for the treatment of retinal degenerative diseases. It d …
  • Linde AG (LIN)-製薬・医療分野:企業M&A・提携分析
    Summary Linde AG (Linde) is a provider of industrial gases and engineering services. The company specializes in the planning, procurement, construction and operation of gas production and processing plants. Linde offers a wide range of compressed and liquefied gases, and chemicals, and offers facili …
  • PetroChina Co Ltd (857):企業の財務・戦略的SWOT分析
    PetroChina Co Ltd (857) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses a …
  • Synexus Ltd-製薬・医療分野:企業M&A・提携分析
    Summary Synexus Ltd (Synexus), a subsidiary of Synexus Clinical Research Limited, is a site management organisation that offers patient recruitment and trial management services. The company services include feasibility assessment, project management, patient engagement, patient-centric clinical tri …
  • Land O’Lakes, Inc.:企業の戦略・SWOT・財務情報
    Land O'Lakes, Inc. - Strategy, SWOT and Corporate Finance Report Summary Land O'Lakes, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Xinjiang Goldwind Science & Technology Co Ltd (002202):電力:M&Aディール及び事業提携情報
    Summary Xinjiang GoldWind Science & Technology Co. Ltd. (Goldwind) is a wind energy company that manufactures wind turbine generator sets, develops wind farms and provides wind power services. The company researches, develops, manufactures and sells wind turbine generators and wind power components. …
  • Bank of Ireland Group plc:企業のM&A・事業提携・投資動向
    Bank of Ireland Group plc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Bank of Ireland Group plc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisi …
  • Enterprise Rent-A-Car Company:企業の戦略・SWOT・財務情報
    Enterprise Rent-A-Car Company - Strategy, SWOT and Corporate Finance Report Summary Enterprise Rent-A-Car Company - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and …
  • Factor Therapeutics Ltd (FTT):医療機器:M&Aディール及び事業提携情報
    Summary Factor Therapeutics Ltd (FTL), formerly Tissue Therapies Ltd, is a developer of wound care therapeutics. The company develops treatments for acute and chronic wound healing applications such as chronic skin ulcers and burns. Its lead therapeutic candidate, VF-001 is a targeted growth factor …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆